Medical Decision Making

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaskin, D. J.
Right arrow Articles by Schulman, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaskin, D. J.
Right arrow Articles by Schulman, K. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Medical Decision Making, Vol. 24, No. 6, 614-624 (2004)
DOI: 10.1177/0272989X04271041
© 2004 Society for Medical Decision Making

An Exploration of Relative Health Stock in Advanced Cancer Patients

Darrell J. Gaskin, PhD

Johns Hopkins University, Baltimore, Maryland

Kevin P. Weinfurt, PhD

Duke University, Durham, North Carolina

Liana D. Castel, MSPH

Duke University, Durham, North Carolina

Venita DePuy, MS

Duke University, Durham, North Carolina

Yun Li, MS

Duke University, Durham, North Carolina

Andrew Balshem, BA

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Al Benson, MD, FACP

Northwestern University, Chicago, Illinois

Caroline B. Burnett, ScD, RN

Georgetown University, Washington, DC

Sandra Corbett, MS

Fox Chase Cancer Center, Philadelphia, Pennsylvania

John Marshall, MD

Georgetown University, Washington, DC

Elyse Slater, MS

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Daniel P. Sulmasy, MD

St. Vincent’s Manhattan and New York Medical College, New York, New York

David Van Echo, MD

University of Maryland, Baltimore

Neal J. Meropol, MD

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Kevin A. Schulman, MD

Duke University, Durham, North Carolina

Objective. The authors sought to empirically test whether relative health stock, a measure of patients’ sense of loss in their health due to illness, influences the treatment decisions of patients facing life-threatening conditions. Specifically, they estimated the effect of relative health stock on advanced cancer patients’ decisions to participate in phase I clinical trials. Method. A multicenter study was conducted to survey 328 advanced cancer patients who were offered the opportunity to participate in phase I trials. The authors asked patients to estimate the probabilities of therapeutic benefits and toxicity, their relative health stock, risk preference, and the importance of quality of life. Results. Controlling for health-related quality of life, an increase in relative health stock by 10 percentage points reduced the odds of choosing to participate in a phase I trial by 16% (odds ratio = 0.84, 95% confidence interval = 0.72, 0.97). Conclusion. Relative health stock affects advanced cancer patients’ treatment decisions.

Key Words: patient preferences • decision making • clinical trials • cancer • phase I trials


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JCOHome page
N. J. Meropol and K. A. Schulman
Cost of Cancer Care: Issues and Implications
J. Clin. Oncol., January 10, 2007; 25(2): 180 - 186.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. P. Weinfurt
Value of High-Cost Cancer Care: A Behavioral Science Perspective
J. Clin. Oncol., January 10, 2007; 25(2): 223 - 227.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Agrawal, C. Grady, D. L. Fairclough, N. J. Meropol, K. Maynard, and E. J. Emanuel
Patients' Decision-Making Process Regarding Participation in Phase I Oncology Research
J. Clin. Oncol., September 20, 2006; 24(27): 4479 - 4484.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S.Y.H. Kim, R. G. Holloway, S. Frank, C. A. Beck, C. Zimmerman, R. Wilson, and K. Kieburtz
Volunteering for early phase gene transfer research in Parkinson disease
Neurology, April 11, 2006; 66(7): 1010 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
E. B. Rasiel, K. P. Weinfurt, and K. A. Schulman
Can Prospect Theory Explain Risk-Seeking Behavior by Terminally Ill Patients?
Med Decis Making, November 1, 2005; 25(6): 609 - 613.
[Abstract] [PDF]